JP2007511493A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007511493A5 JP2007511493A5 JP2006538953A JP2006538953A JP2007511493A5 JP 2007511493 A5 JP2007511493 A5 JP 2007511493A5 JP 2006538953 A JP2006538953 A JP 2006538953A JP 2006538953 A JP2006538953 A JP 2006538953A JP 2007511493 A5 JP2007511493 A5 JP 2007511493A5
- Authority
- JP
- Japan
- Prior art keywords
- autoimmune
- use according
- vascular
- disorder
- rhodococcus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010003816 Autoimmune disease Diseases 0.000 claims 8
- 241000316848 Rhodococcus <scale insect> Species 0.000 claims 5
- 206010052779 Transplant rejections Diseases 0.000 claims 5
- 230000001363 autoimmune Effects 0.000 claims 4
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 claims 4
- 206010059245 Angiopathy Diseases 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 3
- 241001337904 Gordonia <angiosperm> Species 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 210000003205 Muscles Anatomy 0.000 claims 2
- 206010037912 Raynaud's phenomenon Diseases 0.000 claims 2
- 230000001684 chronic Effects 0.000 claims 2
- 230000002757 inflammatory Effects 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 201000011528 vascular disease Diseases 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 206010003230 Arteritis Diseases 0.000 claims 1
- 206010003246 Arthritis Diseases 0.000 claims 1
- 206010000032 Cardiac conduction disease Diseases 0.000 claims 1
- 241000203749 Gordonia bronchialis Species 0.000 claims 1
- 241001509412 Gordonia sputi Species 0.000 claims 1
- 241000203747 Gordonia terrae Species 0.000 claims 1
- 206010022941 Iridocyclitis Diseases 0.000 claims 1
- 208000010125 Myocardial Infarction Diseases 0.000 claims 1
- 208000009525 Myocarditis Diseases 0.000 claims 1
- 210000004165 Myocardium Anatomy 0.000 claims 1
- 241000187654 Nocardia Species 0.000 claims 1
- 241000187678 Nocardia asteroides Species 0.000 claims 1
- 241000187580 Nocardioides Species 0.000 claims 1
- 241000187606 Nocardioides albus Species 0.000 claims 1
- 206010037162 Psoriatic arthropathy Diseases 0.000 claims 1
- 208000003782 Raynaud Disease Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 206010043778 Thyroiditis Diseases 0.000 claims 1
- 210000004026 Tunica Intima Anatomy 0.000 claims 1
- 238000002399 angioplasty Methods 0.000 claims 1
- 201000004612 anterior uveitis Diseases 0.000 claims 1
- 230000036523 atherogenesis Effects 0.000 claims 1
- 230000003143 atherosclerotic Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002357 endometrial Effects 0.000 claims 1
- 201000010238 heart disease Diseases 0.000 claims 1
- 239000002955 immunomodulating agent Substances 0.000 claims 1
- 230000002584 immunomodulator Effects 0.000 claims 1
- 229940121354 immunomodulators Drugs 0.000 claims 1
- 239000003018 immunosuppressive agent Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002107 myocardial Effects 0.000 claims 1
- 230000000414 obstructive Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 201000004681 psoriasis Diseases 0.000 claims 1
- 201000001263 psoriatic arthritis Diseases 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 231100000216 vascular lesion Toxicity 0.000 claims 1
Claims (12)
- 自己免疫疾患又は自己免疫異常を治療又は予防するための医薬品の製造における、ロドコッカス属、ゴルドニア属、ノカルジア属、ダイエツィア属、ツカムレラ属及びノカルジオイデス属の1又は2以上の属に属する細菌の全細胞を含む免疫調節物質組成物又は薬剤組成物の使用。
- 自己免疫疾患又は自己免疫異常が血管内膜の炎症を含む、請求項1に記載の使用。
- 自己免疫疾患又は自己免疫異常が血管筋層又は心筋の炎症をさらに含む、請求項2に記載の使用。
- 自己免疫疾患又は自己免疫異常が、血管障害が先行するもの又は血管障害に起因するものである、請求項1から3のいずれか一項に記載の使用。
- 自己免疫疾患又は自己免疫異常が、関節炎、特に関節リウマチ、乾癬、乾癬性関節症、強皮症、甲状腺炎、移植後の内膜増殖、移植片拒絶及び血管障害の1又は2以上から選択される、請求項1から4のいずれか一項に記載の使用。
- 血管障害が、自己免疫エレメントを含む血管障害である、請求項5に記載の使用。
- 血管障害が、レイノー病又はレイノー現象、前部ブドウ膜炎、閉塞性血管障害、(動脈硬化症としても知られる)アテローム形成、動脈炎、(自然又は血管形成術後の)筋内膜増殖、血管の内膜及び/又は筋層の炎症性及び自己免疫性肥厚、炎症性血管病変、アテローム硬化性心疾患、再潅流傷害、心臓伝導障害、心筋炎、心筋梗塞の1又は2以上から選択される、請求項5又は請求項6に記載の使用。
- 移植片拒絶が慢性移植片拒絶である、請求項5に記載の使用。
- 移植片拒絶が免疫抑制薬の非存在下の慢性移植片拒絶である、請求項5に記載の使用。
- 細菌が、ゴルドニア・ブロンチアリス、ゴルドニア・アマレア、ゴルドニア・スプチ、ゴルドニア・テレア、ノカルジア・アステロイド、ダイエツィア・マリス、ツカムレラ・パウロメタボラ、ロドコッカス・ルベル、ロドコッカス・ロドニイ、ロドコッカス・コルプロフィラス、ロドコッカス・オパカス、ロドコッカス・エリトポレス、ノカルジオイデス・アルバス及びツカムレラ・インコネンシスからなる群の1又は2以上から選択される、請求項1から9のいずれか一項に記載の使用。
- 細菌を死滅させる、請求項1から10のいずれか一項に記載の使用。
- 請求項1から11に実質的に記載された使用。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0326620A GB0326620D0 (en) | 2003-11-14 | 2003-11-14 | Immune modulator |
GB0326620.2 | 2003-11-14 | ||
GB0404102A GB0404102D0 (en) | 2004-02-24 | 2004-02-24 | Immune modulator |
GB0404102.6 | 2004-02-24 | ||
PCT/GB2004/004783 WO2005049056A2 (en) | 2003-11-14 | 2004-11-12 | Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocardioides bacteria |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007511493A JP2007511493A (ja) | 2007-05-10 |
JP2007511493A5 true JP2007511493A5 (ja) | 2007-10-25 |
JP4875494B2 JP4875494B2 (ja) | 2012-02-15 |
Family
ID=34621659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006538953A Expired - Fee Related JP4875494B2 (ja) | 2003-11-14 | 2004-11-12 | 免疫調節物質 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7413728B2 (ja) |
EP (1) | EP1684803B1 (ja) |
JP (1) | JP4875494B2 (ja) |
AR (1) | AR046583A1 (ja) |
AT (1) | ATE473014T1 (ja) |
DE (1) | DE602004028038D1 (ja) |
ES (1) | ES2347566T3 (ja) |
GB (1) | GB2422544B (ja) |
WO (1) | WO2005049056A2 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8501198B2 (en) | 2004-06-07 | 2013-08-06 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
US9107864B2 (en) | 2004-06-07 | 2015-08-18 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
US7442374B2 (en) | 2004-07-19 | 2008-10-28 | Ucl Biomedica Plc | Composition for increasing the survival to slaughter rate of piglets |
GB0526033D0 (en) | 2005-12-21 | 2006-02-01 | Bioeos Ltd | Method |
GB0526032D0 (en) * | 2005-12-21 | 2006-02-01 | Bioeos Ltd | Use |
EP2170082A4 (en) * | 2007-06-29 | 2012-01-11 | Commw Scient Ind Res Org | PROCESS FOR REMOVING TOXIC COMPOUNDS |
GB0716778D0 (en) | 2007-08-29 | 2007-10-10 | Bioeos Ltd | Use |
US20110092589A1 (en) * | 2008-03-10 | 2011-04-21 | The Charlotte-Mecklenburg Hospotal Authority | Treatment of Inflammatory Conditions and Diseases with Metal-Thiols |
EP3235506B1 (en) * | 2010-07-26 | 2023-12-06 | Qu Biologics Inc. | Immunogenic anti-inflammatory compositions |
US8980279B2 (en) | 2010-07-26 | 2015-03-17 | Qu Biologics | Personalized site-specific immunomodulation |
CN106456740B (zh) | 2014-05-02 | 2021-06-08 | Qu生物制药公司 | 抗微生物免疫调节 |
AU2017222692A1 (en) * | 2016-02-25 | 2018-09-27 | Thomas Julius Borody | Compositions and methods of treatment of chronic infectious diseases |
KR20210114436A (ko) * | 2019-01-15 | 2021-09-23 | 랴오닝 그레이티스트 바이오-파마슈티컬 컴퍼니 리미티드 | 로도코커스 루버로부터 유래하는 생성물 및 이의 약학 용도 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL71683A0 (en) | 1984-04-27 | 1984-09-30 | Yeda Res & Dev | Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria |
US4599310A (en) * | 1984-06-18 | 1986-07-08 | Bristol-Myers Company | Process for producing antitumor antibiotic compound |
GB9203814D0 (en) | 1992-02-21 | 1992-04-08 | Univ London | Treatment of long term auto-immune conditions |
ES2128093T3 (es) * | 1994-10-12 | 1999-05-01 | Du Pont | Procedimiento enzimatico para la preparacion de esteres de acidos carboxilicos quirales alfa-terciarios. |
JPH10117633A (ja) * | 1996-10-21 | 1998-05-12 | Mitsui Pharmaceut Inc | 遺伝子欠損動物 |
KR100250830B1 (ko) * | 1997-12-09 | 2000-04-01 | 성재갑 | 자가분해에 의해 폴리하이드록시알킨산으로부터 광학활성을 가진 단량체 하이드록시카르복실산의 제조방법 |
AU3344299A (en) * | 1998-04-20 | 1999-11-08 | Shionogi & Co., Ltd. | Th2-migration promoters containing w/o emulsions |
DE69911401T2 (de) * | 1998-05-20 | 2004-06-24 | Erasmus Universiteit Rotterdam | Immunoregulator |
JPWO2002056911A1 (ja) * | 2000-12-26 | 2004-05-20 | 味の素株式会社 | 移植拒絶反応抑制剤 |
WO2003014309A2 (en) * | 2001-08-07 | 2003-02-20 | Immunex Corporation | Interleukin-1 receptors in the treatment of diseases |
NZ555055A (en) * | 2001-12-11 | 2010-06-25 | Pasteur Institut | Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
WO2004022093A1 (en) | 2002-09-06 | 2004-03-18 | University College London | Whole bacterial cells as immune modulator |
-
2004
- 2004-11-12 US US10/577,907 patent/US7413728B2/en not_active Expired - Fee Related
- 2004-11-12 ES ES04798504T patent/ES2347566T3/es active Active
- 2004-11-12 GB GB0607956A patent/GB2422544B/en not_active Expired - Fee Related
- 2004-11-12 DE DE602004028038T patent/DE602004028038D1/de active Active
- 2004-11-12 AR ARP040104189A patent/AR046583A1/es unknown
- 2004-11-12 JP JP2006538953A patent/JP4875494B2/ja not_active Expired - Fee Related
- 2004-11-12 WO PCT/GB2004/004783 patent/WO2005049056A2/en active Application Filing
- 2004-11-12 AT AT04798504T patent/ATE473014T1/de not_active IP Right Cessation
- 2004-11-12 EP EP04798504A patent/EP1684803B1/en not_active Not-in-force
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007511493A5 (ja) | ||
WO2007015906A3 (en) | Methods and compositions for smooth muscle reconstruction | |
EA200700212A1 (ru) | Многовалентные vla-4 антагонисты, содержащие полимерные фрагменты | |
JP2011504474A5 (ja) | ||
EP2380969A3 (en) | Perivascular mesenchymal precursor cell induced blood vessel formation | |
WO2010057112A3 (en) | Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets | |
WO2007024441A3 (en) | Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof | |
AR021893A1 (es) | Compuesto de 2-fenil-1-(3,4-dihidroxi-5-nitrofenil)-1-etanona sustituida , su uso para la manufactura de un medicamento en el tratamiento de algunos trastornos del sistema nervioso central y periférico y composiciones farmacéuticas que las contienen | |
WO2004096245A3 (en) | Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration | |
UA88634C2 (en) | Quaternized quinuclidine esters | |
Berrios et al. | Depressive illness in multiple sclerosis | |
MX2007000046A (es) | Compuestos, composiciones y metodos de imidazolo relacionados para su uso. | |
WO2007035722A3 (en) | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration | |
Chiba et al. | Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate | |
JP2009519216A5 (ja) | ||
Krantz et al. | Repetitive yawning associated with cardiac tamponade | |
TW200745087A (en) | CCR5 antagonists useful for treating HIV | |
Webster et al. | Fluoroquinolone resistance in renal isolates of Mycobacterium tuberculosis | |
WO2007069927A3 (en) | Methods of the obtaining of olfactory ensheathing cells and their application | |
Raman et al. | The Madras Leper Hospital and leprosy management in 19th century | |
TW200640910A (en) | Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors | |
WO2005103711A3 (en) | Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 1 (cxcr1) | |
WO2004104577A3 (en) | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4) | |
Alahmed | Oral Findings and Buccal Micronucleus Cytome Assay in patients with Rheumatoid arthritis on Methotrexate and Etanercept treatments | |
Grosso et al. | Haploidentical Transplantation In Adults≥ 66 Years of Age |